Article
"This is the paradox of vision: Sharp perception softens our existence in the world."
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Ashvattha reports positive phase 2 data for migaldendranib in retinal diseases
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Sylentis releases topline results from phase 2a of SYL1801
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Q&A: Malvina Eydelman, MD, on leading CCOI and catalyzing global ophthalmic innovation
Q&A: Eva Kim, MD, on the value of EVO ICL for patients considering surgery